• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN Back to Search Results
Catalog Number 03P36-26
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/01/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Patient information: patient identifier: (b)(6).Patient information: no further patient information was provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer observed falsely elevated architect afp result for 1 sample.The following data was provided: on (b)(6) 2019 sid (b)(6) initial result = 157 ng/ml, repeats = 8.7 ng/ml, 9.2 ng/ml.Patient's history = 10 ng/ml.No impact to patient management was reported.
 
Additional Manufacturer Narrative
A review of tickets was performed for reagent lot number 01476fn00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Accuracy testing was performed using an in-house retained kit of lot 01476fn00 and all specifications were met indicating the lot is preforming acceptably.Historical performance of reagent lot 01476fn00 using world wide data was evaluated.The patient median result for the lot is comparable with all other lots in the field and confirms no systemic issue for the lot.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect afp for lot 01476fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Common Device Name
ALPHA-FETOPROTEIN
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8916240
Report Number3008344661-2019-00106
Device Sequence Number10894042
Product Code LOK
UDI-Device Identifier00380740081317
UDI-Public00380740081317
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P120008
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2020
Device Catalogue Number03P36-26
Device Lot Number01476FN00
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/31/2019
Supplement Date Received by Manufacturer10/30/2019
Initial Report FDA Received Date08/21/2019
Supplement Report FDA Received Date10/30/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARCHITECT I2000SR ANALYZER, LIST 03M74-01; ARCHITECT I2000SR PROCESSING MODULE, LIST 03M74-01; SERIAL (B)(4); SERIAL (B)(4)
-
-